The Science & Technology desk gathers a weekly digest of impactful and fascinating analysis publications and developments at Stanford. Read the newest on this week’s Research Roundup.
Stanford researchers develop retinal implant that restores studying capacity in blind sufferers
A microchip smaller than a fingernail, surgically positioned beneath the retina, has restored the power to learn in sufferers who misplaced their sight to dry age-related macular degeneration, the most typical type of incurable blindness in older adults. The microchip operates alongside augmented-reality glasses outfitted with a digicam that captures photographs and tasks them as infrared mild onto the implant’s 378 photovoltaic pixels.
The machine, known as PRIMA, was developed by Stanford ophthalmology professor Daniel Palanker and works by changing infrared mild into {an electrical} present that stimulates surviving retinal neurons, which then relay alerts to the mind.
“It’s basically like solar panels,” Palanker said to Stanford Magazine. “Every pixel is a little solar panel in the eye.”
In a scientific trial which passed off in Europe, 27 of 32 sufferers who accomplished one 12 months of follow-up regained the power to learn letters, numbers and phrases.
The outcomes had been published within the New England Journal of Medicine in Oct. 2025. Science Corporation, which now manufactures PRIMA, expects European regulatory approval by summer season, with U.S. Food and Drug Administration approval pending. Currently, Palanker’s lab is growing a next-generation chip with greater than 10,000 pixels to additional enhance picture decision and allow potential facial recognition.
Stanford research finds intestine micro organism drive age-related memory loss, and the decline could also be reversible
Shifts within the intestine microbiome that happen naturally with getting old impair communication between the intestines and the mind to drive cognitive decline, however restoring that pathway can reverse memory loss, based on a mouse research from Stanford Medicine and the Arc Institute published in Nature.
Researchers discovered that as mice age, their intestine microbiome shifts to favor a bacterium known as Parabacteroides goldsteinii, which raises ranges of medium-chain fatty acids. This triggers an inflammatory response in intestine immune cells, which then disrupts signaling alongside the vagus nerve (the communication freeway between the intestine) and the hippocampus (the mind area accountable for memory).
When researchers stimulated the vagus nerve in previous mice, the animals carried out in addition to younger mice on memory and maze duties.
“The degree of reversibility of age-related cognitive decline in the animals just by altering gut-brain communication was a surprise,” mentioned Christoph Thaiss, assistant professor of pathology and senior creator of the research, according to Stanford Medicine. “We tend to think of memory decline as a brain-intrinsic process.”
Vagus nerve stimulation is already FDA-approved for melancholy and epilepsy. Researchers at the moment are investigating whether or not the identical gut-brain pathway exists in people, and whether or not non-invasive interventions concentrating on intestine microbiome composition might sluggish or reverse cognitive decline.
Stanford researchers develop nasal vaccine that protects in opposition to viruses, micro organism and allergens
In a research published in Science, Stanford Medicine researchers developed a nasal spray vaccine that protects mice in opposition to a variety of respiratory threats, together with a number of coronaviruses, frequent bacterial infections and home mud mite allergens.
The vaccine differs from current vaccines, which practice the immune system to acknowledge particular options of a pathogen. Instead, it mimics the chemical alerts that T cells use to maintain the innate immune system activated within the lungs for weeks to months.
“It’s becoming increasingly clear that many pathogens are able to quickly mutate,” Bali Pulendran, the research’s senior creator and a professor of microbiology and immunology, said to Stanford Medicine. “Like the proverbial leopard that changes its spots, a virus can change the antigens on its surface.”
In vaccinated mice, the innate immune response decreased viral load within the lungs by 700-fold, and any virus that broke by means of was met with a completely activated adaptive response inside three days, in comparison with two weeks in unvaccinated mice. Pulendran estimates a human model could possibly be accessible inside 5 to seven years.